137 related articles for article (PubMed ID: 2945444)
1. Effect of atriopeptin III on hematocrit and volemia of nephrectomized rats.
Flückiger JP; Waeber B; Matsueda G; Delaloye B; Nussberger J; Brunner HR
Am J Physiol; 1986 Oct; 251(4 Pt 2):H880-3. PubMed ID: 2945444
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats.
Almeida FA; Suzuki M; Maack T
Life Sci; 1986 Sep; 39(13):1193-9. PubMed ID: 2943959
[TBL] [Abstract][Full Text] [Related]
3. [Absence of a role for the parasympathetic nervous system in the hemodynamic response to atriopeptin III in the normotensive rat].
Waeber B; Matsueda G; Aubert JF; Nussberger J; Brunner HR
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):817-9. PubMed ID: 2948471
[TBL] [Abstract][Full Text] [Related]
4. The hemodynamic response of conscious normotensive rats to atriopeptin III: Lack of a role of the parasympathetic nervous system.
Waeber B; Matsueda GR; Aubert JF; Nussberger J; Brunner HR
Eur J Pharmacol; 1986 Jun; 125(2):177-84. PubMed ID: 2943597
[TBL] [Abstract][Full Text] [Related]
5. Differential blood pressure response to atriopeptin III and sodium nitroprusside in conscious rats with adrenal medullectomy.
Evéquoz D; Waeber B; Matsueda G; Nussberger J; Brunner HR
Eur J Pharmacol; 1987 Dec; 144(2):217-21. PubMed ID: 2963751
[TBL] [Abstract][Full Text] [Related]
6. Blunted effect of ANP on hematocrit and plasma volume in streptozotocin-induced diabetes mellitus in rats.
Valentin JP; Sechi LA; Humphreys MH
Am J Physiol; 1994 Feb; 266(2 Pt 2):R584-91. PubMed ID: 8141419
[TBL] [Abstract][Full Text] [Related]
7. Atriopeptin inhibits stimulated secretion of adrenocorticotropin in rats: evidence for a pituitary site of action.
Kovács KJ; Antoni FA
Endocrinology; 1990 Dec; 127(6):3003-8. PubMed ID: 2174341
[TBL] [Abstract][Full Text] [Related]
8. Atriopeptin III alters renal medullary hemodynamics and the pressure-diuresis response in rats.
Takezawa K; Cowley AW; Skelton M; Roman RJ
Am J Physiol; 1987 Jun; 252(6 Pt 2):F992-1002. PubMed ID: 2954473
[TBL] [Abstract][Full Text] [Related]
9. Effect of peripherally administered atriopeptin III on water intake in rats.
Kaufman S; Monckton EA
J Physiol; 1988 Feb; 396():379-87. PubMed ID: 2970540
[TBL] [Abstract][Full Text] [Related]
10. The action of atriopeptin III on renal function in two models of chronic renal failure in the rat.
Johns EJ; Rutkowski B
Br J Pharmacol; 1990 Feb; 99(2):317-22. PubMed ID: 2139350
[TBL] [Abstract][Full Text] [Related]
11. Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats.
Luft FC; Lang RE; Aronoff GR; Ruskoaho H; Toth M; Ganten D; Sterzel RB; Unger T
J Pharmacol Exp Ther; 1986 Feb; 236(2):416-8. PubMed ID: 2935624
[TBL] [Abstract][Full Text] [Related]
12. Effect of indomethacin and propranolol on the blood pressure and renin response to atriopeptin III in conscious rats.
Flückiger JP; Waeber B; Nussberger J; Matsueda G; Brunner HR
Regul Pept; 1987 May; 17(5):277-84. PubMed ID: 3037621
[TBL] [Abstract][Full Text] [Related]
13. Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptide.
Valentin JP; Ribstein J; Nafrialdi N; Mimran A
Can J Physiol Pharmacol; 1997 Sep; 75(9):1142-7. PubMed ID: 9365827
[TBL] [Abstract][Full Text] [Related]
14. Arterial reactivity, blood pressure, and plasma levels of atrial natriuretic peptides in normotensive and hypertensive rats: effects of acute and chronic administration of atriopeptin III.
De Mey JG; Defreyn G; Lenaers A; Calderon P; Roba J
J Cardiovasc Pharmacol; 1987 May; 9(5):525-35. PubMed ID: 2439832
[TBL] [Abstract][Full Text] [Related]
15. Effect of nicardipine and atriopeptin on transcapillary shift of fluid and proteins.
Valentin JP; Ribstein J; Mimran A
Am J Physiol; 1989 Jul; 257(1 Pt 2):R174-9. PubMed ID: 2526593
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic responses to atrial natriuretic factor in nephrectomized rabbits: attenuation of the circulatory consequences of acute volume expansion.
Volpe M; Vecchione F; Cuocolo A; Lembo G; Pignalosa S; Condorelli M; Trimarco B
Circ Res; 1988 Aug; 63(2):322-9. PubMed ID: 2969306
[TBL] [Abstract][Full Text] [Related]
17. Alterations in systemic haemodynamics induced by atriopeptin III.
Marks ES; Zukowska-Grojec Z; Ropchak T; Keiser HR
J Hypertens; 1987 Feb; 5(1):39-46. PubMed ID: 2953784
[TBL] [Abstract][Full Text] [Related]
18. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic haemodynamic and natriuretic effects of atriopeptin II in conscious rats.
Hofbauer KG; Criscione L; Sonnenburg C; Muir A; Mah SC
J Hypertens Suppl; 1986 Jun; 4(2):S41-7. PubMed ID: 2941543
[TBL] [Abstract][Full Text] [Related]
20. Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome.
Valentin JP; Ying WZ; Couser WG; Humphreys MH
Am J Physiol; 1998 Mar; 274(3):F556-63. PubMed ID: 9530272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
